Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Fawwad Qureshi, Chief Financial Officer, will present at the 46th Annual Raymond James ...

With a rising number of pet owners and increased spending, the pet industry is demonstrating strong growth potential.

Research analysts at William Blair cut their Q1 2025 EPS estimates for Trupanion in a note issued to investors on Thursday, ...

Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...

A downtrend has been apparent in Trupanion (TRUP) lately with too much selling pressure. The stock has declined 26.7% over ...

Lake Street analyst Ryan Meyers maintained a Buy rating on Trupanion (TRUP – Research Report) today and set a price target of $65.00. The ...

Piper Sandler lowered the firm’s price target on Trupanion (TRUP) to $52 from $57 and keeps an Overweight rating on the shares. While Trupanion ...

Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results ...

Trupanion, Inc.’s TRUP share price has dipped by 25.49%, which has investors questioning if this is right time to buy.

Trupanion (TRUP) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.05 per share a year ago. These figures are ...

Trupanion reported mixed earnings with revenue exceeding expectations despite a shortfall in earnings per share (EPS).